About the Company
We do not have any company description for BiomX Inc. at the moment.
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on BiomX Inc.
BiomX Inc. (AMEX:PHGE) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 13, 2025 BiomX Inc. beats earnings expectations. Reported EPS is $-0.19, expectations ...
BiomX Inc. Reports Q2 2025 Progress and Financials
Biomx Inc. ( ($PHGE) ) has released its Q2 earnings. Here is a breakdown of the information Biomx Inc. presented to its investors. BiomX Inc., a ...
BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates
Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot osteomyelitis patients ...
BiomX Inc. Reports Positive Phase 2 Results for BX211 in ... - Nasdaq
BiomX Inc. announced encouraging topline results from its Phase 2 trial for BX211, a treatment aimed at diabetic foot osteomyelitis (DFO), highlighting significant reductions in ulcer size and ...
BiomX Inc. to Report Q4 and Full Year 2024 Financial Results ... - Nasdaq
BiomX Inc., a clinical-stage company specializing in phage therapies targeting harmful bacteria, announced it will release its fourth quarter and full year 2024 financial results on March 25, 2025.
PHGE Stock Quote Price and Forecast | CNN
View BiomX Inc. PHGE stock quote prices, financial information, real-time forecasts, and company news from CNN.
BiomX Announces Third Quarter 2024 Financial Results and Provides ...
BiomX will host a conference call and webcast on November 14, 2024, at 8:00 a.m. ET to discuss its third quarter 2024 financial results and to provide a corporate update. ParticipantDial-In Number: ...
BiomX Inc. (PHGE) latest press releases and corporate news – Yahoo ...
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure NESS ZIONA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a ...
BiomX Inc. secures $12 million from recent offerings
In a recent development, BiomX (NYSE: PHGE) Inc., a company specializing in biological products with a current market capitalization of $11.78 million, disclosed the successful closure of a funding ...
BiomX Reports Third Quarter 2020 Financial Results and Announces ...
BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies targeting specific pathogenic bacteria, t ...
BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript
Thank you, and welcome to the BiomX conference call to review the company's second quarter 2025 financial results and provide an update on our business and programs. Later today, we will file the ...
BiomX Inc: BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates
Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot osteomyelitis patients; Planning underway for potential registrational study Nature Communication ...
Similar Companies
Loading the latest forecasts...